Progressive myoclonus epilepsy - Revision history

Prab: CSV import

2025-04-04T04:09:25Z

CSV import

← Older revision		Revision as of 04:09, 4 April 2025
Line 1:		Line 1:

			{{Infobox medical condition
			\| name = Progressive myoclonus epilepsy
			\| synonyms = [[PME]]
			\| field = [[Neurology]]
			\| symptoms = [[Myoclonus]], [[seizures]], [[ataxia]], [[dementia]]
			\| onset = [[Childhood]] or [[adolescence]]
			\| duration = [[Chronic]]
			\| causes = [[Genetic disorder]]
			\| risks = [[Family history]]
			\| diagnosis = [[Clinical diagnosis]], [[genetic testing]]
			\| differential = [[Epilepsy]], [[Lafora disease]], [[Unverricht-Lundborg disease]]
			\| treatment = [[Anticonvulsants]], [[physical therapy]], [[occupational therapy]]
			\| prognosis = [[Variable]], often [[progressive]]
			\| frequency = Rare
			}}
	'''Progressive Myoclonus Epilepsy''' ('''PME''') is a group of diseases characterized by myoclonus, epilepsy, and progressive neurological decline. These diseases are rare. PME accounts for less than 1% of all cases of epilepsy. The two most common forms of PME are Unverricht-Lundborg disease and Lafora disease.		'''Progressive Myoclonus Epilepsy''' ('''PME''') is a group of diseases characterized by myoclonus, epilepsy, and progressive neurological decline. These diseases are rare. PME accounts for less than 1% of all cases of epilepsy. The two most common forms of PME are Unverricht-Lundborg disease and Lafora disease.

	== Symptoms ==		== Symptoms ==
	The symptoms of PME include [[myoclonus]], [[epilepsy]], and a progressive neurological decline. Other symptoms may include ataxia, dementia, and visual loss.		The symptoms of PME include [[myoclonus]], [[epilepsy]], and a progressive neurological decline. Other symptoms may include ataxia, dementia, and visual loss.

	== Causes ==		== Causes ==
	PME is usually caused by genetic mutations and can be inherited in an autosomal recessive manner. The specific genes involved can vary depending on the specific type of PME.		PME is usually caused by genetic mutations and can be inherited in an autosomal recessive manner. The specific genes involved can vary depending on the specific type of PME.

	== Diagnosis ==		== Diagnosis ==
	Diagnosis of PME is based on clinical features, neurophysiological and imaging studies, and genetic testing. The diagnosis is often delayed due to the rarity of the condition and the variability of symptoms.		Diagnosis of PME is based on clinical features, neurophysiological and imaging studies, and genetic testing. The diagnosis is often delayed due to the rarity of the condition and the variability of symptoms.

	== Treatment ==		== Treatment ==
	Treatment for PME is symptomatic and supportive. Medications may be used to manage myoclonus and seizures. Physical therapy may be beneficial for some patients.		Treatment for PME is symptomatic and supportive. Medications may be used to manage myoclonus and seizures. Physical therapy may be beneficial for some patients.

	== Prognosis ==		== Prognosis ==
	The prognosis for individuals with PME varies depending on the specific type of PME and the severity of symptoms. In general, the disease is progressive and may lead to disability and life-threatening complications.		The prognosis for individuals with PME varies depending on the specific type of PME and the severity of symptoms. In general, the disease is progressive and may lead to disability and life-threatening complications.

	== See also ==		== See also ==
	* [[Epilepsy]]		* [[Epilepsy]]
	* [[Myoclonus]]		* [[Myoclonus]]
	* [[Neurological disorder]]		* [[Neurological disorder]]

	== References ==		== References ==
	<references />		<references />

	[[Category:Neurological disorders]]		[[Category:Neurological disorders]]
	[[Category:Epilepsy]]		[[Category:Epilepsy]]
	[[Category:Rare diseases]]		[[Category:Rare diseases]]

	{{stub}}		{{stub}}
	{{No image}}		{{No image}}

Prab at 13:10, 18 March 2025

2025-03-18T13:10:02Z

← Older revision		Revision as of 13:10, 18 March 2025
Line 30:		Line 30:
	{{stub}}		{{stub}}
	{{No image}}		{{No image}}
	~~__NOINDEX__~~

Prab: CSV import

2025-03-18T00:02:18Z

CSV import

← Older revision		Revision as of 00:02, 18 March 2025
Line 30:		Line 30:
	{{stub}}		{{stub}}
	{{No image}}		{{No image}}
			__NOINDEX__

Prab: CSV import

2025-02-10T20:53:54Z

CSV import

← Older revision		Revision as of 20:53, 10 February 2025
Line 29:		Line 29:

	{{stub}}		{{stub}}
			{{No image}}

Prab: CSV import

2024-02-25T14:12:27Z

CSV import

New page

'''Progressive Myoclonus Epilepsy''' ('''PME''') is a group of diseases characterized by myoclonus, epilepsy, and progressive neurological decline. These diseases are rare. PME accounts for less than 1% of all cases of epilepsy. The two most common forms of PME are Unverricht-Lundborg disease and Lafora disease.

== Symptoms ==
The symptoms of PME include [[myoclonus]], [[epilepsy]], and a progressive neurological decline. Other symptoms may include ataxia, dementia, and visual loss.

== Causes ==
PME is usually caused by genetic mutations and can be inherited in an autosomal recessive manner. The specific genes involved can vary depending on the specific type of PME.

== Diagnosis ==
Diagnosis of PME is based on clinical features, neurophysiological and imaging studies, and genetic testing. The diagnosis is often delayed due to the rarity of the condition and the variability of symptoms.

== Treatment ==
Treatment for PME is symptomatic and supportive. Medications may be used to manage myoclonus and seizures. Physical therapy may be beneficial for some patients.

== Prognosis ==
The prognosis for individuals with PME varies depending on the specific type of PME and the severity of symptoms. In general, the disease is progressive and may lead to disability and life-threatening complications.

== See also ==
* [[Epilepsy]]
* [[Myoclonus]]
* [[Neurological disorder]]

== References ==
<references />

[[Category:Neurological disorders]]
[[Category:Epilepsy]]
[[Category:Rare diseases]]

{{stub}}